GLGLENVIEW CAPITAL MANAGEMENT, LLC

Institutional investor · Portfolio as of Q1 2021

Top Holdings63 positions

Checking export access…
Activity:

TENET HEALTHCARE CORP

13.7M$713.7M12.1%$17.82+191.87%
10 qtrssince 2018-Q4
Decreased
0

BAUSCH HEALTH COS INC

15.6M$495.6M8.4%$22.28+42.49%
10 qtrssince 2018-Q4
Decreased
0

THE CIGNA GROUP

1.9M$449.4M7.6%$177.51+23.03%
10 qtrssince 2018-Q4
Increased
83

MCKESSON CORP

1.8M$343.4M5.8%$134.99+41.67%
10 qtrssince 2018-Q4
Increased
84

DXC TECHNOLOGY CO

10.6M$330.8M5.6%$47.55-34.26%
10 qtrssince 2018-Q4
Increased
63
TAKTAK
ADR

TAKEDA PHARMACEUTICAL CO LTD

16.1M$294.1M5.0%$18.73-8.27%
9 qtrssince 2019-Q1
Increased
60

CENCORA INC

1.8M$214.2M3.6%$91.34+19.65%
10 qtrssince 2018-Q4
Increased
91

HCA HEALTHCARE INC

1.1M$201.6M3.4%$119.49+51.49%
10 qtrssince 2018-Q4
Decreased
0

UNIVERSAL HLTH SVCS INC

1.2M$154.6M2.6%$115.43+15.09%
10 qtrssince 2018-Q4
Increased
81

META PLATFORMS INC

491,855$144.9M2.5%$291.32+0.14%
2 qtrssince 2020-Q4
Increased
84

ALPHABET INC

65,934$136M2.3%$93.50+9.26%
10 qtrssince 2018-Q4
Increased
84
NUANNUANDelisted

NUANCE COMMUNICATIONS INC

3.1M$134.9M2.3%——
10 qtrssince 2018-Q4
Increased
68

BOSTON SCIENTIFIC CORP

3.2M$123.6M2.1%$35.28+9.54%
5 qtrssince 2020-Q1
Increased
61

BAXTER INTL INC

1.4M$116.2M2.0%$74.34+2.12%
5 qtrssince 2020-Q1
Increased
76

BROOKDALE SENIOR LIVING INC

18M$109.2M1.9%$6.13+0.90%
10 qtrssince 2018-Q4
Increased
47

FISERV INC

877,447$104.5M1.8%$113.90+4.51%
7 qtrssince 2019-Q3
Increased
73

FMC CORP

859,688$95.1M1.6%$59.98+55.14%
10 qtrssince 2018-Q4
Increased
56

ELEVANCE HEALTH INC FORMERLY

263,633$94.6M1.6%$306.50+8.21%
2 qtrssince 2020-Q4
Increased
63

HUMANA INC

193,938$81.3M1.4%$331.50+20.11%
10 qtrssince 2018-Q4
Increased
56

BUTTERFLY NETWORK INC

4.8M$80.4M1.4%$17.370.00%
1 qtr
New
68
$5.9B
AUM
63
Positions
Q1 2021
Filing
HI score · 3.0/5
Quarterly 13F Value Change
+20%Q4'19$11.4B-68%Q1'20$3.7B-1%Q2'20$3.6B-12%Q3'20$3.2B+37%Q4'20$4.4B+35%Q1'21$5.9B
Activity profile
$ moved · Q1'21
New20%Increased52%Decreased19%Exited10%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.2 years
<1Q27%1-4Q13%1-2Y17%2Y+43%

GLENVIEW CAPITAL MANAGEMENT, LLC manages $5.9B across 63 positions as of Q1 2021. Top holdings: THC (12.1%), BHC (8.4%), CI (7.6%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 3/5.0.

Q1 2021 Summary

Active quarter - 20 new positions, 11 exits, 28 increased. Top move: COR (INCREASED, conviction 91). Portfolio: $5.9B across 63 positions.

Top holdings by portfolio weight

Total AUM$6B
THC12.09%
BHC8.40%
CI7.61%
MCK5.82%
DXC5.60%
TAK4.98%
COR3.63%
HCA3.42%
UHS2.62%
META2.45%
Other2.30%

Portfolio allocation by GICS sector

Sectors9
Healthcare65.66%
Unknown9.70%
Technology7.94%
Basic Materials4.81%
Communication Services4.80%
Industrials4.16%
Consumer Defensive1.22%
Financial Services0.91%
Consumer Cyclical0.80%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Healthcare
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Solid(3.0 / 5.0)
Holdings P&L66
Conviction48
Concentration88
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
5Q
GPNGPNGLOBAL PMTS INC
Q2 2025 → Q2 2026+5.1M shares+$274.8M
4Q
AMZNAMZNAMAZON COM INC
Q3 2025 → Q2 2026+708,813 shares+$179.6M
4Q
EYEEYENATIONAL VISION HLDGS INC
Q3 2025 → Q2 2026+2.3M shares+$40.3M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used